News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Investor
Merck & Co. (MRK) CEO Ken Frazier Is A Quote Machine 12/5/2016
KaloBios (KBIO) Highlights Priority Milestones In Letter To Stakeholders 12/5/2016
Osiris (OSIR) Provides Update Regarding NASDAQ Listing Matters 12/5/2016
GTx, Inc. (GTXI) Announces 1-for-10 Reverse Stock Split 12/5/2016
Oculus Innovative Sciences (OCLS) Announces Corporate Name Change To Sonoma Pharmaceuticals, Inc. And New NASDAQ Ticker Symbol To Better Align With Dermatology Focus 12/5/2016
Pfizer Ventures And TVM Life Science Ventures VII Announce Additional Investment In Ixchelsis 12/5/2016
A Look at Gilead (GILD) and Its Potential $10 Billion Blunder 12/2/2016
The Controversial Biotech Billionaire Who Dined With Trump 12/2/2016
A Few Billionaires Are Turning Medical Philanthropy On Its Head 12/2/2016
2 Bay Area and 1 Massachusetts Biotech Stocks That Could Double in 2017 12/2/2016
3 Biotech Stocks to Pick Up Before the New Year 12/2/2016
3 Toxic Biotech Stocks to Stay Away From in 2017 12/2/2016
Another Reason Biotech's Trump-Bump Won't Last 12/2/2016
Becton, Dickinson and Company (BDX) Announces Early Tender Results And Upsizing Of Maximum Tender Offers 12/2/2016
Pfenex (PFNX) Reports New Employment Inducement Award Under NYSE MKT Listing Rules 12/2/2016
Allergan (AGN) Provides Update on Accelerated Share Repurchase (ASR) Program 12/2/2016
Protalix (PLX) Announces Private Note Exchanges And Private Placement Of Secured Convertible Notes Due 2021 12/2/2016
Quark Venture Invests $4 Million In A New Technology That Harnesses The Body’s Natural Immune System To Combat Disease 12/2/2016
CEL-SCI (CVM) Announces Pricing Of $4.25 Million Public Offering Of Common Stock And Warrants 12/2/2016
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 12/2/2016
Genetic Technologies Limited (GTG.AX) Announces Offering Of USD 6.0 Million Of American Depository Shares 12/2/2016
OrthoSpace Completes Equity Financing Round 12/2/2016
Landauer (LDR) Declares Regular Cash Dividend 12/2/2016
Palatin Tech (PTN) Announces Pricing Of Public Offering Of Common Stock And Warrants 12/2/2016
TSO3 (TOS) Receives 2017 Purchase Orders From Getinge 12/2/2016
After Eli Lilly (LLY)'s Flop, Could Alzheimer's Become Healthcare's Trumpshot? 12/1/2016
10 Lessons For Building A Game-Changing Biotech Company 12/1/2016
This One Biopharma Made the 10 Richest Companies in the U.S. List 12/1/2016
How Theranos' Big Investors Were Taken 12/1/2016
AzurRx BioPharma (AZRX) CEO Provides Shareholders With A "State Of The Union" Communication 12/1/2016
Minomic Announces Completion Of Oversubscribed Capital Raising At AGM 12/1/2016
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 12/1/2016
Provectus Announces Notification Of NYSE MKT Listing Deficiency 12/1/2016
Palatin Tech (PTN) Announces Proposed Public Offering Of Common Stock And Warrants 12/1/2016
Xencor Announces Proposed Public Offering Of Common Stock 12/1/2016
GenVec (GNVC) Effects 1-for-10 Reverse Stock Split 12/1/2016
Xencor Prices Public Offering Of Common Stock 12/1/2016
Bactiguard AB: Exercise Of Call Options 12/1/2016
Invitation To Presentation Of Sectra (SECTB)’s Six-Month Report On December 12 12/1/2016
A Look at the Top 5 Biotech Stock Performers of 2016 11/30/2016
Q Biomed Announces Entry Into Definitive Funding Agreement For Up To $4,000,000 11/30/2016
Portage Biotech Announces Spin-Out Of EyGen 11/30/2016
Cellectar Biosciences  (CLRB) Announces Successful Completion Of $9.2 Million Public Offering, Which Includes Full Exercise Of $1.2 Million Over-Allotment Option 11/30/2016
TRACON Pharma (TCON) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares 11/30/2016
Nabriva Announces Terms Of Rights Offering 11/30/2016
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 11/30/2016
New Market Research On Synthetic Biology, Covering Opportunities And Threats In Personal Care, Announced By Kline And Promotum, Inc. 11/30/2016
Hutchison China MediTech (Chi-Med): Total Voting Rights 11/30/2016
Hutchison China MediTech (Chi-Med): Exercise Of Share Options 11/30/2016
Vernalis PLC (VNLPY.PK): AGM Statement 11/30/2016
Spotlight Innovation Makes Strategic Investment In Solx, Inc. 11/30/2016
5 Biotechs That Have Potential Catalysts By the End of the Year 11/29/2016
3 Reasons Big Hedge Funds Dropped Allergan (AGN) Like a Hot Potato in Q3 11/29/2016
3 Slow and Steady Biotech Stocks for Your Retirement Portfolio 11/29/2016
Sorrento (SRNE) Secures $75 Million Loan Facility 11/29/2016
BioPharmX Announces Closing Of A $12.5 Million Unit Offering 11/29/2016
Cipher Pharma (DND.TO) Announces Plans To Voluntarily Delist From NASDAQ 11/29/2016
Collegium (COLL) Announces Underwriters’ Exercise Of Option To Purchase Additional Shares 11/29/2016
Indian Pharma Companies Forecast 30% Growth In 2017 At CPhI India 11/29/2016
Angle: Issue Of Share Options 11/29/2016
Endonovo Signs Term Sheet For $5 Million To Redeem All Outstanding Convertible Notes And Prepare To Uplist Its Common Stock 11/29/2016
InfuSystem Holdings, Inc. (HAPN.OB) Announces Notification Of Noncompliance With NYSE MKT Continued Listing Standards 11/29/2016
Misonix (MSON) Reports Nasdaq's Acceptance Of Its Plan To Regain Listing Compliance 11/29/2016
Varian Medical Systems (VAR) Schedules Annual Stockholder Meeting In Palo Alto 11/29/2016
3 Biotech Investing Tips That Could Earn You Thousands 11/28/2016
5 Beaten-Down Biotech Stocks Billionaire Financier George Soros Bought in Q3 11/28/2016
Cascadian Therapeutics (ONTY) Announces Stockholders And Board Of Directors Approve Reverse Stock Split 11/28/2016
Inovio Pharma (INO) Applies To Cease Reporting To Canadian Securities Regulatory Authorities; NASDAQ Listing And US Reporting Unaffected 11/28/2016
Catalent (CTLT) Announces Launch Of Private Offering Of $400 Million (U.S. Dollar Equivalent) Of Euro-Denominated Senior Unsecured Notes Due 2024 11/28/2016
Suven Life Sciences Ltd Revenue Growth At 13.42%; PAT Up By 29.15% For The Half Year Ended Sept, 2016 11/28/2016
Hutchison China MediTech (Chi-Med): Director's Share Dealing 11/28/2016
3 Predictions for Intuitive Surgical (ISRG) in 2017 11/28/2016
Bioren, Inc. Announces Orders Totalling $4.8 Million 11/28/2016
WaferGen Biosystems Announces 1-For-5 Reverse Stock Split 11/28/2016
When Will Gilead (GILD)'s Unlucky Streak End? 11/23/2016
3 Big Name Biotechs That Could Easily Pay Dividends, But Don't 11/23/2016
3 Reasons Intrexon (XON) Stock Could Fall 11/23/2016
How To Be A Smarter Biotech Investor 11/23/2016
5 Drug Giants That Could Dominate the $13 Billion Alzheimer's Market 11/23/2016
This Drug Could be Inovio Pharma (INO)'s Best Chance for Success 11/23/2016
What Trump Isn't Saying About Drugmakers Matters 11/23/2016
PDL BioPharma (PDLI) Issues $150.0 Million of 2.75% Convertible Senior Notes Due 2021 11/23/2016
Achaogen (AKAO) Announces New Employment Inducement Grants 11/23/2016
TRACON Pharma (TCON) Announces Pricing Of Public Offering Of Common Stock 11/23/2016
Cellectar Biosciences  (CLRB) Announces Pricing Of $8,000,000 Public Offering 11/23/2016
Jaguar Animal Health Announces Private Placement Of Common Stock And Warrants 11/23/2016
Vasuda Global Orphan/Rare Disease Index Announces The Quarterly Recomposition And Rebalancing 11/23/2016
Trump's Pick For Attorney General Could Be Big Boost To Monsanto (MON) 11/22/2016
Biotech Venture Capital Mythbusting Redux 11/22/2016
Biotech Should Cash In Its Trump Bump Right Now 11/22/2016
2 Excellent Dividend-Paying Drug Stocks To Add To Your Portfolio 11/22/2016
3 Reasons Investors May Want To Sell Johnson & Johnson (JNJ) Stock 11/22/2016
5 Biotech Stocks On The Brink Of Major Breakouts 11/22/2016
Neurosearch A/S (NEUR.CO) Announces Main Components Of Resolution Plan 11/22/2016
It's Already Black Friday for Investors With These 3 Biotechs 11/22/2016
BioPharmX Announces Pricing Of Unit Offering 11/22/2016
Becton, Dickinson and Company (BDX) Board Increases Dividend 11/22/2016
Nabriva Announces Change In Record Date For Planned Rights Offering 11/22/2016
Osiris (OSIR) Provides Update Regarding NASDAQ Listing Matters 11/22/2016
Dow Chemical  (DOW) Release: Andrew Liveris Discusses Growth Opportunities In Saudi Arabia 11/22/2016
Immune Pharma Announces Immuno-Oncology R&D Update On December 8, 2016 11/22/2016
Top 8 Pharma Companies That Paid the Least in Taxes and How They Will Fare Under Trump 11/21/2016
Valeant (VRX) - The Asset Seller That Cried "Wolf" 11/21/2016
3 Stocks That May Appeal to New Biotech Investors 11/21/2016
BioStem Technologies Opens New Sudsidiary Qualified Pharma Ingredients, Inc. 11/21/2016
ESSA Pharma Secures US$10 Million Term Loan From Silicon Valley Bank 11/21/2016
Synthetic Biologics (SYN) Announces Closing Of Public Offering Of Common Stock And Warrants 11/21/2016
Roche Holding AG (RHHBF.PK) Announces Debt Tender Offer For Up To $250 Million Aggregate Purchase Price Of Its 7.00% Notes Due 2039 11/21/2016
aTyr Pharma Enters Into $20 Million Credit Facility 11/21/2016
Pfizer (PFE) Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019 11/21/2016
Merz Pharma Group Continues Its Growth In Aesthetics And Neurotoxins 11/21/2016
Astex Pharma (ASTX) Joins The Dementia Discovery Fund As A Strategic Investor 11/21/2016
Pfizer (PFE) Announces Pricing Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019 11/21/2016
Daxor Corporation (DXR) Announces Dividend, Patent Approval, Title Change 11/21/2016
Zimmer Biomet Announces Cash Tender Offers For Up To $1.1 Billion Aggregate Purchase Price Of Certain Outstanding Debt Securities 11/21/2016
Varian Medical Systems (VAR) Board Of Directors Authorizes Repurchase Of Additional 8 Million Shares Of Stock 11/21/2016
EXACT Sciences (EXAS) Grants Inducement Restricted Stock Unit Awards To Recently Hired Employees 11/21/2016
Does Gilead (GILD) Pass Warren Buffett's Test? 11/18/2016
3 Things Comeback Kid Exelixis (EXEL) Needs to Do to Succeed in 2017 11/18/2016
3 Stocks to Add to Your Portfolio as Biotech M&A Hopes Rise 11/18/2016
Catalyst Driver For PDL BioPharma (PDLI) Is Coming 11/18/2016
Janus Portfolio Manager Sees More Biotech Gains On Trump 11/18/2016
Famed Short-Seller Says This Drug Stock is One You Need to Drop ASAP 11/18/2016
Apama Medical Closes $19.5 Million In Series C Equity And Debt Financing, Presents First In Human Data At AHA's Scientific Sessions 2016 11/18/2016
PharmAthene, Inc. (PIP) Declares $2.91 Special Cash Dividend On Common Stock 11/18/2016
Neurotrope Announces Private Placement of $20 Million 11/18/2016
Aclaris (ACRS) Announces Pricing Of Public Offering Of Common Stock 11/18/2016
Supernus (SUPN) Receives Nasdaq Non-Compliance Notice 11/18/2016
Agilent (A) Increases Cash Dividend To 13.2 Cents Per Share 11/18/2016
PharmAthene, Inc. (PIP) Receives Final Payment From SIGA (SIGA) Of $83.9 Million 11/17/2016
PDL BioPharma (PDLI) Prices Public Offering Of $150.0 Million Of 2.75% Convertible Senior Notes Due 2021 11/17/2016
Merus (MRUS) Receives Nasdaq Notice Regarding Minimum Bid Price Requirements 11/17/2016
Becton, Dickinson and Company (BDX) Announces Tender Offers For Outstanding Debt Securities 11/17/2016
Aclaris (ACRS) Announces Proposed Public Offering Of Common Stock 11/17/2016
AmpliPhi Bio (APHB) Announces Pricing Of Public Offering Of Common Stock And Warrants 11/17/2016
Invitae Announces Pricing Of Public Offering Of Common Stock 11/17/2016
Alexion (ALXN) Receives NASDAQ Notification Related To The Late Filing Of Form 10-Q 11/17/2016
SIGA (SIGA) Announces Successful Completion Of Rights Offering; Funding Of Loan; Completion Of Payment Of Pharmathene Obligation 11/17/2016
Pharma Shares Flying Out Of Windows Of First-Class Car On The Trump Train 11/16/2016
How Much Of A Gamble Is Investing In CRISPR? 11/16/2016
5 Biotech Stocks Poised to Grow in Trumpworld 11/16/2016
PDL BioPharma (PDLI) Announces Proposed $150 Million Public Offering of New Convertible Senior Notes Due 2021 11/16/2016
ImmunoCellular Therapeutics, Ltd (IMUC) Announces One-for-Forty Reverse Stock Split 11/16/2016
MorphoSys AG To Raise Capital Via A Private Placement Of New Shares 11/16/2016
WaferGen Biosystems Announces Stockholder Approval Of Merger With Takara Bio 11/16/2016
Israeli Billionaire Nacht Bets Big Money on Another Teva (TEVA) 11/15/2016
Why Pharma Needs To Invest In Discovery 11/15/2016
Cash to Operate a Growing Concern for Bay Area's VistaGen 11/15/2016
Tauriga (TAUG) To Form Wholly Owned Subsidiary Focused On The Development, Marketing And Distribution Of Products That Target Muscle Tension 11/15/2016
Carl Icahn Quietly Reduces Stake in Allergan (AGN) 11/15/2016
Pfizer (PFE) Prices $6,000,000,000 Debt Offering 11/15/2016
Synthetic Biologics (SYN) Announces Commencement Of Public Offering Of Common Stock And Warrants 11/15/2016
SciClone (SCLN) Confirms Receipt Of Unsolicited Proposal From GL Capital And ABG Management 11/15/2016
Synthetic Biologics (SYN) Announces Pricing Of Public Offering Of Common Stock And Warrants 11/15/2016
AC Immune SA Announces Results Of Annual General Meeting 11/15/2016
MabVax Therapeutics To Hold Conference Call To Provide Corporate Update On Monday, November 14, 2016 11/15/2016
Anatara Lifesciences Chairman's Address To Shareholders 11/15/2016
Pressure BioSciences, Inc. (BBII) Announces Initial Close Of $610,000 In $2.5 Million Private Placement 11/15/2016
Abbott (ABT) CEO Buys $15 Million in Stock 11/15/2016
Misonix (MSON) Reports Receipt Of Deficiency Letter From The Nasdaq Stock Market 11/15/2016
BIO Loves Newt: A Backdoor Into A Trump Administration? 11/14/2016
3 Biotechs That Might Have Paid Lower Taxes Than You and I in 2015 11/14/2016
Trump Presidency Could Bode Well For Pharma, Devicemakers 11/14/2016
3 Reasons That Make Biogen (BIIB) the King of a Crumbling Empire 11/14/2016
Donald Trump's Victory Gives U.S. Drugmakers A Tonic 11/14/2016
6 Thoughts On President Trump And The Durability Of The Biotech Stock Rally 11/14/2016
Nabriva Announces Planned Rights Offering And Sets Record Date 11/14/2016
Pfizer (PFE) Announces Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019 11/14/2016
Supernus (SUPN) Provides Business Update 11/14/2016
PAREXEL (PRXL) Launches IDMP-Focused Software And Service Solution 11/14/2016
Tesaro (TSRO) Announces Proposed Public Offering Of Common Stock 11/14/2016
Syros Pharma Reports Third Quarter 2016 Financial Results And Provides Business Update 11/14/2016
Samsung Biologics 's Next Cash Cow Could Be This $8 Billion Contract Drugmaker 11/11/2016
Valeant (VRX) May Seek Name Change to Clean Up Its Image 11/11/2016
Here Are 3 Ways To Play The Growing Market For Vaccines Right Now 11/11/2016
Despite Scarce Resources, Juno (JUNO) Still Impressed With Its Expansion in China 11/11/2016
Why Investors Should Buy (and Avoid) Merck & Co. (MRK) 11/11/2016
PRA Health Sciences Announces Secondary Offering Of 7,500,000 Shares Of Common Stock 11/11/2016
Shire (SHPG)'s Investor Day Showcases Strength Of Rare Disease Pipeline And Commercial Portfolio 11/11/2016
Is A Donald Trump Presidency A Black Swan Event For Pharma Stocks? 11/10/2016
Alexion (ALXN) Provides Update On Form 10-Q Filing 11/10/2016
XTL Biopharma (XTLB) Receives NASDAQ Notification Regarding Minimum Bid Requirements 11/10/2016
Hologic (HOLX) Announces Upcoming Put Option And Notice Of Redemption Of 2.00% Convertible Exchange Senior Notes Due 2037 11/10/2016
Big Pharma's Big Question: Is Trump Friend Or Foe? 11/9/2016
Biotech Stocks Jump as Donald Trump Clinches Presidency in Major Upset 11/9/2016
Champion Of Biotech Fights Off A Strong Re-Election Challenge 11/9/2016
Why Valeant (VRX) Can't "Dig Out Of That Hole" Fast Enough 11/9/2016
3 Pharmas Relying on Innovation, Not Drug Price Increases for Growth 11/9/2016
Osiris (OSIR) Stock Soars After Giving First Glimpse of Its Financials Since Last Year 11/9/2016
Record Growth For IDIFARMA 11/9/2016
Perrigo (PRGO) Announces Quarterly Dividend 11/9/2016
TapImmune (TPIV) Commences Trading On The Nasdaq Capital Market 11/9/2016
CytoDyn (CYDY) Announces Webcast Of Investment Community Presentation On November 11 11/9/2016
Bactiguard AB: The Main Shareholders Issue A Loan Commitment 11/9/2016
Elekta’s Nomination Committee For The 2017 Annual General Meeting 11/9/2016
2 Biotech Stocks to Have in Your Portfolio if Donald Trump Wins the Election 11/8/2016
How Illumina (ILMN) Stacks Up Against Warren Buffet's Acquisition Criteria 11/8/2016
With No Products and a Very Weak Revenue, Here's What Makes Kite Pharma (KITE) So Mighty 11/8/2016
Zomedica Retains Renmark Financial Communications To Enhance Investor Outreach And Extends Equity Offering 11/8/2016
QLT (QLTI) Announces Shareholder Approval Of Matters Related To Strategic Merger And Record Date For Distribution Of Warrants 11/8/2016